Viridian Pharmaceuticals is a company that is bringing clinically-driven CBD products to the main market. They recently launched a new product, called Notion.
Notion is a topical formula that is rich in CBD and that features a clinical roadmap and proven delivery pathway. The delivery system is based on molecules, which work to absorb into the skin. Upon absorption, the formula may be able to provide men and women with the CBD relief that they are striving for. In addition, the company is researching the absorption qualities and its impact on conditions as well.
Layne Beal, the company’s COE, stated,
“Our first commercial product, Notion, is based on our proprietary CBD delivery technology.”
“Our company was born from biopharma and comes from a heritage of clinical studies and R&D, which is what formed the only topical delivery system that has been shown to use the skin as a delivery portal for CBD — an effective alternative to consumers who want to experience the benefits of CBD without having to smoke or ingest it.”
The formula is not the brand’s only effort. The company is working to develop other commercial products and to research the clinical path more closely so as to develop a solution for consumers’ needs.
“Our delivery technology bypasses the body’s metabolic processes and is absorbed quickly. We have performed bioavailability analysis and pharmacokinetic studies on our formulation to demonstrate efficacy, and are excited to look into how CBD coupled with our delivery technology may impact migraines and osteoarthritis, the first two indications we’re planning to investigate.”
Continue to look for more news and updates about the clinically-driven Notion CBD cream by Viridian Pharmaceuticals.